Issn Print: 0923-7534
Publication Date: 2018/02/01
A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)
L Zhang; S Lu; J Feng; A Dechaphunkul; J Chang; D Wang; S Chessari; C Lanzarotti; K Jordan; M Aapro
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.